Denver Investment Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Denver Investment Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$41K	Sell	13,846 -3,183	-19%	-$8.69K	﹤0.01%	414
2017 Q4	$47K	Hold	17,029	–	–	﹤0.01%	422
2017 Q3	$58K	Buy	+17,029	New	+$47.4K	﹤0.01%	439
2016 Q4	–	Sell	-11,453	Closed	-$38K	–	528
2016 Q3	$38K	Sell	11,453 -822	-7%	-$2.61K	﹤0.01%	442
2016 Q2	$39K	Sell	12,275 -2,574	-17%	-$8.58K	﹤0.01%	454
2016 Q1	$49K	Sell	14,849 -4,701	-24%	-$14.7K	﹤0.01%	461
2015 Q4	$69K	Buy	+19,550	New	+$81.8K	﹤0.01%	492

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Denver Investment Advisors's PDLI Position: Q1 2018 in Review

Denver Investment Advisors reduced its PDL BioPharma, Inc. (PDLI) stake by 19% in Q1 2018, selling an estimated $8.69K and leaving 13,846 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #414.

Denver Investment Advisors first reported a position in PDLI in Q4 2015 and has held it in 7 quarters since. The position peaked at $69K in Q4 2015. 176 funds tracked by Wall St. Rank hold PDLI as of Q1 2018.

Denver Investment Advisors held 13,846 shares of PDL BioPharma, Inc. worth $41K as of Q1 2018.
Denver Investment Advisors sold 3,183 PDL BioPharma, Inc. shares in Q1 2018, an estimated $8.69K.
PDL BioPharma, Inc. made up ﹤0.01% of Denver Investment Advisors's portfolio in Q1 2018, its #414 holding.
Denver Investment Advisors first reported a position in PDL BioPharma, Inc. in Q4 2015 and has held it in 7 quarters since.
Denver Investment Advisors's PDL BioPharma, Inc. position peaked at $69K in Q4 2015.
176 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2018.

Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.